| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |